Patents, Trade Marks, Designs, Copyrights, IP Solicitors, Appeals and Oppositions, Due Diligence and Strategy.

HGF offers everything you would expect of a world-class intellectual property firm, including patent and trade mark acquisition as well as appeals and oppositions to protect your creative work.

We also focus on providing a bespoke service tailored to your industry, to ensure you really get the most out of your big ideas. Our teams are dedicated to providing professional, expert advice and support every step of the way.

The latest news and cutting edge commentary from across the group

April 2018
April 2018

IPTA Annual Conference

Lee Curtis will be speaking at the Institute of Patent and Trade Mark Attorneys of Australia (IPTA) Annual Conference in Melbourne between 18th and 21st April 2018.

Find out more
February 2018
February 2018

Swiss Nordic Bio

Patent Director Marie-Louise Jardle will be attending Swiss Nordic Bio in Switzerland on 8th February 2018.

Find out more
January 2018
January 2018

Arab Health 2018

HGF Partner Vanessa Stainthorpe, and Patent Director Kieran Killough, will be attending Arab Health 29th Jan – 1st Feb 2018.

Find out more
January 2018

2nd Annual Microbiome Drug Development Summit Europe

HGF Partner, Craig Thomson, will be speaking at this year's Annual Microbiome Drug Development Summit being held in Paris from 29th January - 1st February 2018.

Find out more
January 2018

The 8th China IP International Annual Forum

HGF Partners Hsu Min Chung and Dr Christopher Benson will be speaking at the 8th China IP International Annual Forum in Beijing, China, January 25-28th 2018.

Find out more
January 2018

GIPC 2018

Martyn Fish and Andy Camenisch are speaking at the 2018 Global Intellectual Property Convention (GIPC) in Bangalor, India in January.

Find out more
January 2018

Broad CRISPR/cas9 patent revoked in Europe

The Opposition Division of the European Patent Office has issued its Decision on the key issue of priority for Broad’s CRISPR/cas9 patent EP 2 771 468. This Decision will also affect Broad’s other CRISPR/cas9 patents in Europe where Rockefeller University was not named as an applicant at t…

Broad CRISPR/cas9 patent revoked in Europe Find out more